GW Pharmaceuticals Market Cap 2013-2018 | GWPH
GW Pharmaceuticals market cap history and chart from 2013 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. GW Pharmaceuticals market cap as of March 21, 2019 is $5.14B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $5.140B | $0.013B |
| GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $140.412B | 27.76 |
| Medtronic (MDT) | Ireland | $123.010B | 17.98 |
| Stryker (SYK) | United States | $73.467B | 26.97 |
| Boston Scientific (BSX) | United States | $52.473B | 25.58 |
| Baxter (BAX) | United States | $39.558B | 25.31 |
| Zimmer Biomet Holdings (ZBH) | United States | $26.051B | 16.68 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.542B | 0.00 |
| Canopy Growth (CGC) | Canada | $15.685B | 0.00 |
| ResMed (RMD) | United States | $14.159B | 26.85 |
| Aurora Cannabis (ACB) | Canada | $9.930B | 70.07 |
| Bio-Rad Laboratories (BIO) | United States | $9.309B | 53.12 |
| Hill-Rom Holdings (HRC) | United States | $6.934B | 21.44 |
| Perrigo (PRGO) | Ireland | $6.569B | 10.65 |
| Insulet (PODD) | United States | $5.896B | 1989.40 |
| ICU Medical (ICUI) | United States | $4.857B | 30.24 |
| Haemonetics (HAE) | United States | $4.425B | 39.25 |
| Hutchison China MediTech (HCM) | China | $3.913B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.752B | 0.00 |
| Neogen (NEOG) | United States | $3.328B | 51.11 |
| NuVasive (NUVA) | United States | $2.858B | 24.93 |
| Quidel (QDEL) | United States | $2.654B | 23.95 |
| Aphria (APHA) | $2.533B | 112.44 | |
| National Vision Holdings (EYE) | United States | $2.263B | 44.51 |
| HEXO (HEXO) | $1.414B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.377B | 988.50 |
| VAREX IMAGING (VREX) | United States | $1.295B | 25.34 |
| Phibro Animal Health (PAHC) | United States | $1.292B | 18.57 |
| AtriCure (ATRC) | United States | $1.089B | 0.00 |
| MacroGenics (MGNX) | United States | $0.939B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.930B | 25.13 |
| Cerus (CERS) | United States | $0.874B | 0.00 |
| Omeros (OMER) | United States | $0.861B | 0.00 |
| PetIQ (PETQ) | United States | $0.843B | 24.12 |
| NanoString Technologies (NSTG) | United States | $0.751B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.722B | 21.52 |
| OraSure Technologies (OSUR) | United States | $0.705B | 30.89 |
| Evolus (EOLS) | United States | $0.685B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.667B | 22.70 |
| TG Therapeutics (TGTX) | United States | $0.655B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.609B | 28.99 |
| Surmodics (SRDX) | United States | $0.603B | 87.71 |
| Quanterix (QTRX) | United States | $0.545B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.376B | 154.92 |
| Rockwell Medical (RMTI) | United States | $0.367B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.352B | 0.00 |
| Vapotherm (VAPO) | United States | $0.330B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.315B | 20.48 |
| Owens & Minor (OMI) | United States | $0.284B | 3.94 |
| Bovie Medical (APYX) | United States | $0.266B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.265B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.260B | 0.00 |
| Zynex (ZYXI) | United States | $0.144B | 15.37 |
| Fonar (FONR) | United States | $0.142B | 7.59 |
| Surface Oncology (SURF) | United States | $0.126B | 0.00 |
| Chimerix (CMRX) | United States | $0.102B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.099B | 0.00 |
| Female Health (VERU) | United States | $0.095B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 18.43 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.087B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.086B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.071B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.070B | 20.71 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.057B | 0.00 |
| Neurotrope (NTRP) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.037B | 0.00 |
| Senestech (SNES) | United States | $0.027B | 0.00 |
| Myomo (MYO) | United States | $0.021B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.017B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.016B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 16.00 |
